n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide and imetelstat

n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide has been researched along with imetelstat* in 1 studies

Other Studies

1 other study(ies) available for n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide and imetelstat

ArticleYear
Anemia in myelofibrosis-prevalence, the U2AF1 connection, new treatments.
    Blood cancer journal, 2017, 12-15, Volume: 7, Issue:12

    Topics: Anemia; Benzamides; Enzyme Inhibitors; Humans; Mutation; Oligonucleotides; Primary Myelofibrosis; Pyrimidines; Splicing Factor U2AF

2017